InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,214.08
(
0.51%
)
US TECH 100
17,716.80
(
0.43%
)
Dow Jones
39,387.76
(
0.85%
)
Brent Oil
84.24
(
0.34%
)
Bitcoin
62,898.51
(
-0.24%
)
Post# of 20775
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

john1045

Send PM Follow Ignore
Followers 36
Posts 2689
Boards Moderated 0
Alias Born 06/09/2011

john1045

Re: None

Thursday, 08/18/2016 5:11:34 AM

Thursday, August 18, 2016 5:11:34 AM

Post# of 20775
Not sure if this was posted end of July or early August but it was updated on July 29, 2016 to Study has Been Completed

https://www.clinicaltrials.gov/ct2/show/NCT01898884?term=Shire+friedreich%27s+ataxia&rank=1

Safety and Pharmacology Study of VP 20629 in Adults With Friedreich's Ataxia


This study has been completed.

Sponsor:

Shire

Information provided by (Responsible Party):

Shire


ClinicalTrials.gov Identifier:

NCT01898884

First received: July 3, 2013

Last updated: July 29, 2015

Last verified: July 2015

History of Changes
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up